{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T02:49:09Z","timestamp":1764557349130},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T00:00:00Z","timestamp":1444694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/nrgastro.2015.172","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T09:53:45Z","timestamp":1444730025000},"page":"639-648","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Keys to long-term care of the liver transplant recipient"],"prefix":"10.1038","volume":"12","author":[{"given":"Kymberly D.","family":"Watt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,13]]},"reference":[{"key":"BFnrgastro2015172_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/SLA.0b013e3182a15db4","volume":"258","author":"VG Agopian","year":"2013","unstructured":"Agopian, V. G.  et al. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Ann. Surg. 258, 409\u2013421 (2013).","journal-title":"Ann. Surg."},{"key":"BFnrgastro2015172_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jhep.2014.03.034","volume":"61","author":"AM Allen","year":"2014","unstructured":"Allen, A. M.  et al. Chronic kidney disease and associated mortality after liver transplantation\u2014a time-dependent analysis using measured glomerular filtration rate. J. Hepatol. 61, 286\u2013292 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015172_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/lt.21978","volume":"16","author":"GW McCaughan","year":"2010","unstructured":"McCaughan, G. W., Shackel, N. A., Strasser, S. I., Dilworth, P. & Tang, P. Minimal but significant improvement in survival for non-hepatitis C-related adult liver transplant patients beyond the one-year posttransplant mark. Liver Transpl. 16, 130\u2013137 (2010).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR4","unstructured":"Scientific Registry of Transplant Recipients \n                    [online]\n                    \n                  , (2015)."},{"key":"BFnrgastro2015172_CR5","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/hep.27538","volume":"61","author":"F Aberg","year":"2015","unstructured":"Aberg, F.  et al. Differences in long-term survival among liver transplant recipients and the general population: A population-based nordic study. Hepatology 61, 668\u2013677 (2015).","journal-title":"Hepatology"},{"key":"BFnrgastro2015172_CR6","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","volume":"141","author":"MR Charlton","year":"2011","unstructured":"Charlton, M. R.  et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 141, 1249\u20131253 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015172_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-6143.2010.03126.x","volume":"10","author":"K Watt","year":"2010","unstructured":"Watt, K., Pedersen, R., Kremers, W., Heimbach, J. & Charlton, M. Evolution of causes and risk factors for mortality post liver transplant: results of the NIDDK Long Term Follow-up Study. Am. J. Transplant. 10, 1\u20138 (2010).","journal-title":"Am. J. Transplant."},{"key":"BFnrgastro2015172_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1053\/j.gastro.2014.10.001","volume":"148","author":"M Charlton","year":"2015","unstructured":"Charlton, M.  et al. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation. Gastroenterology 148, 108\u2013117 (2015).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015172_CR9","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1056\/NEJMoa1408921","volume":"371","author":"PY Kwo","year":"2014","unstructured":"Kwo, P. Y.  et al. An interferon-free antiviral regimen for HCV after liver transplantation. N. Engl. J. Med. 371, 2375\u20132382 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2015172_CR10","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1097\/TP.0000000000000659","volume":"99","author":"MD Burgio","year":"2015","unstructured":"Burgio, M. D.  et al. Follow-up imaging after liver transplantation should take into consideration primary hepatocellular carcinoma characteristics. Transplantation 99, 1613\u20131618 (2015).","journal-title":"Transplantation"},{"key":"BFnrgastro2015172_CR11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4254\/wjh.v7.i2.276","volume":"7","author":"A Pecchi","year":"2015","unstructured":"Pecchi, A.  et al. Post-transplantation hepatocellular carcinoma recurrence: patterns and relation between vascularity and differentiation degree. World J. Hepatol. 7, 276\u2013284 (2015).","journal-title":"World J. Hepatol."},{"key":"BFnrgastro2015172_CR12","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/lt.21475","volume":"14","author":"F Aberg","year":"2008","unstructured":"Aberg, F., Pukkala, E., Hockerstedt, K., Sankila, R. & Isoniemi, H. Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl. 14, 1428\u20131436 (2008).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR13","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/lt.23478","volume":"18","author":"E Rothbaum Perito","year":"2012","unstructured":"Rothbaum Perito, E., Lau, A., Rhee, S., Roberts, J. P. & Rosenthal, P. Posttransplant metabolic syndrome in children and adolescents after liver transplantation: a systematic review. Liver Transpl. 18, 1009\u20131028 (2012).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1399-3046.2006.00567.x","volume":"10","author":"DA Kelly","year":"2006","unstructured":"Kelly, D. A. Current issues in pediatric transplantation. Pediatr. Transplant. 10, 712\u2013720 (2006).","journal-title":"Pediatr. Transplant."},{"key":"BFnrgastro2015172_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1053\/jlts.2001.27084","volume":"7","author":"J Pruthi","year":"2001","unstructured":"Pruthi, J.  et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl. 7, 811\u2013815 (2001).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0002-9610(01)00595-5","volume":"181","author":"JM Rabkin","year":"2001","unstructured":"Rabkin, J. M.  et al. Late mortality after orthotopic liver transplantation. Am. J. Surg. 181, 475\u2013479 (2001).","journal-title":"Am. J. Surg."},{"key":"BFnrgastro2015172_CR17","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1053\/jlts.2001.28645","volume":"7","author":"JJ Fung","year":"2001","unstructured":"Fung, J. J.  et al. De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl. 7, S109\u2013S118 (2001).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR18","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/lt.23722","volume":"19","author":"H Schrem","year":"2013","unstructured":"Schrem, H.  et al. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection. Liver Transpl. 19, 1252\u20131261 (2013).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR19","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1053\/j.gastro.2009.08.070","volume":"137","author":"K Watt","year":"2009","unstructured":"Watt, K., Pedersen, R., Heimbach, J., Kremers, W. & Gores, G. Probability and mortality of de novo malignancy after liver transplantation: results of the multicentered, prospective NIDDK long term database. Gastroenterology 137, 2010\u20132017 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015172_CR20","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/lt.20525","volume":"11","author":"JI Herrero","year":"2005","unstructured":"Herrero, J. I.  et al. Nonmelanoma skin cancer after liver transplantation. Study of risk factors. Liver Transpl. 11, 1100\u20131106 (2005).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.critrevonc.2005.03.015","volume":"56","author":"AL Taylor","year":"2005","unstructured":"Taylor, A. L., Marcus, R. & Bradley, J. A. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit. Rev. Oncol. Hematol. 56, 155\u2013167 (2005).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"BFnrgastro2015172_CR22","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/lt.23741","volume":"19","author":"S Singh","year":"2013","unstructured":"Singh, S., Edakkanambeth Varayil, J., Loftus, E. V., Jr & Talwalkar, J. A. Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis. Liver Transpl. 19, 1361\u20131369 (2013).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR23","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/hep.24570","volume":"54","author":"N Razumilava","year":"2011","unstructured":"Razumilava, N., Gores, G. J. & Lindor, K. D. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 54, 1842\u20131852 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro2015172_CR24","doi-asserted-by":"crossref","unstructured":"Lucey, M. R.  et al. Long-Term Management of the Successful Adult Liver Transplant: 2012 Practice Guideline by AASLD and the American Society of Transplantation \n                    [online]\n                    \n                  , (2012).","DOI":"10.1002\/lt.23566"},{"key":"BFnrgastro2015172_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1478-3231.2011.02575.x","volume":"32","author":"J Fevery","year":"2012","unstructured":"Fevery, J.  et al. Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study. Liver Int. 32, 214\u2013222 (2012).","journal-title":"Liver Int."},{"key":"BFnrgastro2015172_CR26","unstructured":"U.S. Preventive Services Task Force. Final Recommendation Statement Lung Cancer: Screening \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrgastro2015172_CR27","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1056\/NEJMoa1209120","volume":"368","author":"TR Church","year":"2013","unstructured":"Church, T. R.  et al. Results of initial low-dose computed tomographic screening for lung cancer. N. Engl. J. Med. 368, 1980\u20131991 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2015172_CR28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.12659\/AOT.884021","volume":"18","author":"JI Herrero","year":"2013","unstructured":"Herrero, J. I.  et al. Lung cancer screening with low-radiation dose computed tomography after liver transplantation. Ann. Transplant. 18, 587\u2013592 (2013).","journal-title":"Ann. Transplant."},{"key":"BFnrgastro2015172_CR29","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/lt.23531","volume":"18","author":"N Chandok","year":"2012","unstructured":"Chandok, N. & Watt, K. D. Burden of de novo malignancy in the liver transplant recipient. Liver Transpl. 18, 1277\u20131289 (2012).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR30","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/j.1440-1746.2011.06981.x","volume":"27","author":"JI Herrero","year":"2012","unstructured":"Herrero, J. I. Screening of de novo tumors after liver transplantation. J. Gastroenterol. Hepatol. 27, 1011\u20131016 (2012).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2015172_CR31","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1600-6143.2004.00380.x","volume":"4","author":"S Benlloch","year":"2004","unstructured":"Benlloch, S.  et al. De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am. J. Transplant. 4, 596\u2013604 (2004).","journal-title":"Am. J. Transplant."},{"key":"BFnrgastro2015172_CR32","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1111\/j.1600-6143.2009.02766.x","volume":"9","author":"A Finkenstedt","year":"2009","unstructured":"Finkenstedt, A.  et al. Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients. Am. J. Transplant. 9, 2355\u20132361 (2009).","journal-title":"Am. J. Transplant."},{"key":"BFnrgastro2015172_CR33","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.bpobgyn.2014.09.002","volume":"28","author":"C Krajewski","year":"2014","unstructured":"Krajewski, C. & Sucato, G. Reproductive health care after transplantation. Best Pract Res. Clin. Obstet. Gynaecol. 28, 1222\u20131234 (2014).","journal-title":"Best Pract Res. Clin. Obstet. Gynaecol."},{"key":"BFnrgastro2015172_CR34","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1111\/ajt.12472","volume":"13","author":"MM Madeleine","year":"2013","unstructured":"Madeleine, M. M., Finch, J. L., Lynch, C. F., Goodman, M. T. & Engels, E. A. HPV-related cancers after solid organ transplantation in the United States. Am. J. Transplant. 13, 3202\u20133209 (2013).","journal-title":"Am. J. Transplant."},{"key":"BFnrgastro2015172_CR35","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/ajt.12192","volume":"13","author":"R Na","year":"2013","unstructured":"Na, R.  et al. De novo cancer-related death in Australian liver and cardiothoracic transplant recipients. Am. J. Transplant. 13, 1296\u20131304 (2013).","journal-title":"Am. J. Transplant."},{"key":"BFnrgastro2015172_CR36","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/lt.22468","volume":"18","author":"M Albeldawi","year":"2012","unstructured":"Albeldawi, M.  et al. Cumulative risk of cardiovascular events after orthotopic liver transplantation. Liver Transpl. 18, 370\u2013375 (2012).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR37","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/lt.24137","volume":"21","author":"LA Fussner","year":"2015","unstructured":"Fussner, L. A.  et al. Cardiovascular disease after liver transplantation. When, what and who is at risk. Liver Transpl. 21, 889\u2013896 (2015).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/lt.22198","volume":"17","author":"I Laish","year":"2011","unstructured":"Laish, I.  et al. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl. 17, 15\u201322 (2011).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR39","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/lt.21588","volume":"4","author":"G Bianchi","year":"2008","unstructured":"Bianchi, G., Marchesini, G., Marzocchi, R., Pinna, A. & Zoli, M. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl. 4, 1648\u20131654 (2008).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR40","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/lt.21126","volume":"13","author":"M Laryea","year":"2007","unstructured":"Laryea, M.  et al. Metabolic syndrome in liver transplant recipients: prevalence and association with cardiovascular events. Liver Transpl. 13, 1109\u20131114 (2007).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR41","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.transproceed.2014.05.023","volume":"46","author":"AM Garcia","year":"2014","unstructured":"Garcia, A. M., Veneroso, C. E., Soares, D. D., Lima, A. S. & Correia, M. I. Effect of a physical exercise program on the functional capacity of liver transplant patients. Transplant. Proc. 46, 1807\u20131808 (2014).","journal-title":"Transplant. Proc."},{"key":"BFnrgastro2015172_CR42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/lt.500040402","volume":"4","author":"JE Everhart","year":"1998","unstructured":"Everhart, J. E.  et al. Weight change and obesity after liver transplantation: incidence and risk factors. Liver Transpl. Surg. 4, 285\u2013296 (1998).","journal-title":"Liver Transpl. Surg."},{"key":"BFnrgastro2015172_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1432-2277.2004.00067.x","volume":"18","author":"J Richards","year":"2005","unstructured":"Richards, J., Gunson, B., Johnson, J. & Neuberger, J. Weight gain and obesity after liver transplantation. Transpl. Int. 18, 461\u2013466 (2005).","journal-title":"Transpl. Int."},{"key":"BFnrgastro2015172_CR44","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/liv.12495","volume":"34","author":"LR Anastacio","year":"2014","unstructured":"Anastacio, L. R.  et al. Prospective evaluation of metabolic syndrome and its components among long-term liver recipients. Liver Int. 34, 1094\u20131101 (2014).","journal-title":"Liver Int."},{"key":"BFnrgastro2015172_CR45","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1432-2277.2006.00379.x","volume":"19","author":"D Cassiman","year":"2006","unstructured":"Cassiman, D.  et al. Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial. Transpl. Int. 19, 1000\u20131005 (2006).","journal-title":"Transpl. Int."},{"key":"BFnrgastro2015172_CR46","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1600-6143.2012.04318.x","volume":"13","author":"JK Heimbach","year":"2013","unstructured":"Heimbach, J. K.  et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am. J. Transplant. 13, 363\u2013368 (2013).","journal-title":"Am. J. Transplant."},{"key":"BFnrgastro2015172_CR47","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/lt.23734","volume":"19","author":"AR Al-Nowaylati","year":"2013","unstructured":"Al-Nowaylati, A. R.  et al. Gastric bypass after liver transplantation. Liver Transpl. 19, 1324\u20131329 (2013).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00464-012-2410-5","volume":"27","author":"MY Lin","year":"2013","unstructured":"Lin, M. Y.  et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. Surg. Endosc. 27, 81\u201385 (2013).","journal-title":"Surg. Endosc."},{"issue":"Suppl 2","key":"BFnrgastro2015172_CR49","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1002\/lt.21913","volume":"15","author":"GP Pageaux","year":"2009","unstructured":"Pageaux, G. P., Faure, S., Bouyabrine, H., Bismuth, M. & Assenat, E. Long-term outcomes of liver transplantation: diabetes mellitus. Liver Transpl. 15 (Suppl 2), S79\u2013S82 (2009).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR50","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.2337\/dc12-0413","volume":"35","author":"SE Inzucchi","year":"2012","unstructured":"Inzucchi, S. E.  et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes care 35, 1364\u20131379 (2012).","journal-title":"Diabetes care"},{"key":"BFnrgastro2015172_CR51","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrneph.2015.59","volume":"11","author":"T Jenssen","year":"2015","unstructured":"Jenssen, T. & Hartmann, A. Emerging treatments for post-transplantation diabetes mellitus. Nat. Rev. Nephrol. 11, 465\u2013477 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrgastro2015172_CR52","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James, P. A.  et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311, 507\u2013520 (2014).","journal-title":"JAMA"},{"key":"BFnrgastro2015172_CR53","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/jlts.2000.9737","volume":"6","author":"SC Textor","year":"2000","unstructured":"Textor, S. C., Taler, S. J., Canzanello, V. J., Schwartz, L. & Augustine, J. E. Posttransplantation hypertension related to calcineurin inhibitors. Liver Transpl. 6, 521\u2013530 (2000).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR54","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1177\/106002808802200914","volume":"22","author":"TG Maggio","year":"1988","unstructured":"Maggio, T. G. & Bartels, D. W. Increased cyclosporine blood concentrations due to verapamil administration. Drug Intell. Clin. Pharm. 22, 705\u2013707 (1988).","journal-title":"Drug Intell. Clin. Pharm."},{"key":"BFnrgastro2015172_CR55","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/lt.21442","volume":"14","author":"A Galioto","year":"2008","unstructured":"Galioto, A.  et al. Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: results of a controlled clinical trial. Liver Transpl. 14, 1020\u20131028 (2008).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR56","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/01.TP.0000116418.78963.DC","volume":"77","author":"D Neal","year":"2004","unstructured":"Neal, D., Brown, M., Wilkinson, I., Byrne, C. & Alexander, G. Hemodynamic effects of amlodipine, bisoprolol, and lisinopril in hypertensive patients after liver transplantation. Transplantation 77, 748\u2013750 (2004).","journal-title":"Transplantation"},{"key":"BFnrgastro2015172_CR57","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1097\/MJT.0b013e3181df8df5","volume":"18","author":"G Abbas","year":"2011","unstructured":"Abbas, G., Silveira, M. G. & Lindor, K. D. Hepatic fibrosis and the renin-angiotensin system. Am. J. Ther. 18, e202\u2013e208 (2011).","journal-title":"Am. J. Ther."},{"key":"BFnrgastro2015172_CR58","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1681\/ASN.2005090955","volume":"17","author":"G Heinze","year":"2006","unstructured":"Heinze, G.  et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J. Am. Soc. Nephrol. 17, 889\u2013899 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrgastro2015172_CR59","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/ndt\/gfr276","volume":"27","author":"D Hernandez","year":"2012","unstructured":"Hernandez, D.  et al. Renin-angiotensin system blockade and kidney transplantation: a longitudinal cohort study. Nephrol. Dial. Transplant. 27, 417\u2013422 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrgastro2015172_CR60","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2152\/jmi.53.159","volume":"53","author":"T Ogata","year":"2006","unstructured":"Ogata, T., Nomura, M., Nakaya, Y. & Ito, S. Evaluation of episodes of sleep apnea in patients with liver cirrhosis. J. Med. Invest. 53, 159\u2013166 (2006).","journal-title":"J. Med. Invest."},{"key":"BFnrgastro2015172_CR61","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/lt.24100","volume":"21","author":"R Chhatrala","year":"2015","unstructured":"Chhatrala, R.  et al. Evolution of the serum atherogenic risk in liver transplant recipients; role of lipoproteins, metabolic and inflammatory markers. Liver Transpl. 21, 623\u2013630 (2015).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP.18.S1.1","volume":"18","author":"P Jellinger","year":"2012","unstructured":"Jellinger, P.  et al. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocr. Pract. 18, 1\u201378 (2012).","journal-title":"Endocr. Pract."},{"key":"BFnrgastro2015172_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"NJ Stone","year":"2013","unstructured":"Stone, N. J.  et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 129, 1\u201345 (2013).","journal-title":"Circulation"},{"key":"BFnrgastro2015172_CR64","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jacl.2014.02.011","volume":"8","author":"H Bays","year":"2014","unstructured":"Bays, H., Cohen, D. E., Chalasani, N., Harrison, S. A. & The National Lipid Association's Statin Safety Task, F. An assessment by the Statin Liver Safety Task Force: 2014 update. J. Clin. Lipidol. 8, 47\u201357 (2014).","journal-title":"J. Clin. Lipidol."},{"key":"BFnrgastro2015172_CR65","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/lt.21710","volume":"15","author":"F Almutairi","year":"2009","unstructured":"Almutairi, F.  et al. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia. Liver Transpl. 15, 504\u2013508 (2009).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR66","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccl.2015.02.007","volume":"33","author":"EA Brinton","year":"2015","unstructured":"Brinton, E. A. Management of Hypertriglyceridemia for Prevention of Atherosclerotic Cardiovascular Disease. Cardiol. Clin. 33, 309\u2013323 (2015).","journal-title":"Cardiol. Clin."},{"key":"BFnrgastro2015172_CR67","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0140-6736(00)03641-2","volume":"357","author":"G Leidig-Bruckner","year":"2001","unstructured":"Leidig-Bruckner, G.  et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 357, 342\u2013347 (2001).","journal-title":"Lancet"},{"key":"BFnrgastro2015172_CR68","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00296-006-0196-2","volume":"27","author":"P Pennisi","year":"2007","unstructured":"Pennisi, P.  et al. Pamidronate and osteoporosis prevention in liver transplant recipients. Rheumatol. Int. 27, 251\u2013256 (2007).","journal-title":"Rheumatol. Int."},{"key":"BFnrgastro2015172_CR69","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/lt.20160","volume":"10","author":"MM Guichelaar","year":"2004","unstructured":"Guichelaar, M. M., Malinchoc, M., Sibonga, J., Clarke, B. L. & Hay, J. E. Immunosuppressive and postoperative effects of orthotopic liver transplantation on bone metabolism. Liver Transpl. 10, 638\u2013647 (2004).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR70","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1093\/ndt\/gfr214","volume":"26","author":"R Westenfeld","year":"2011","unstructured":"Westenfeld, R.  et al. Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis\u2014implications for post-transplantation bone disease. Nephrol. Dial. Transplant. 26, 4115\u20134123 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrgastro2015172_CR71","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/lt.20466","volume":"11","author":"G Millonig","year":"2005","unstructured":"Millonig, G.  et al. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study. Liver Transpl. 11, 960\u2013966 (2005).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015172_CR72","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1097\/TP.0b013e3182384aff","volume":"92","author":"M Cantarovich","year":"2011","unstructured":"Cantarovich, M.  et al. Early changes in kidney function predict long-term chronic kidney disease and mortality in patients after liver transplantation. Transplantation 92, 1358\u20131363 (2011).","journal-title":"Transplantation"},{"key":"BFnrgastro2015172_CR73","doi-asserted-by":"publisher","first-page":"845438","DOI":"10.1155\/2014\/845438","volume":"2014","author":"GB Klintmalm","year":"2014","unstructured":"Klintmalm, G. B. & Nashan, B. The role of mTOR inhibitors in liver transplantation: reviewing the evidence. J. Transplant 2014, 845438 (2014).","journal-title":"J. Transplant"},{"key":"BFnrgastro2015172_CR74","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.bpobgyn.2014.07.021","volume":"28","author":"C Blume","year":"2014","unstructured":"Blume, C., Pischke, S., von Versen-Hoynck, F., Gunter, H. H. & Gross, M. M. Pregnancies in liver and kidney transplant recipients: a review of the current literature and recommendation. Best Pract. Res. Clin. Obstet. Gynaecol. 28, 1123\u20131136 (2014).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"BFnrgastro2015172_CR75","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","volume":"62","author":"L Park-Wyllie","year":"2000","unstructured":"Park-Wyllie, L.  et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62, 385\u2013392 (2000).","journal-title":"Teratology"},{"key":"BFnrgastro2015172_CR76","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00007890-199708270-00002","volume":"64","author":"A Jain","year":"1997","unstructured":"Jain, A.  et al. Pregnancy after liver transplantation under tacrolimus. Transplantation 64, 559\u2013565 (1997).","journal-title":"Transplantation"},{"key":"BFnrgastro2015172_CR77","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/00007890-199402270-00004","volume":"57","author":"VT Armenti","year":"1994","unstructured":"Armenti, V. T.  et al. National transplantation Pregnancy Registry\u2014outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 57, 502\u2013506 (1994).","journal-title":"Transplantation"},{"key":"BFnrgastro2015172_CR78","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1097\/00007890-200012270-00010","volume":"70","author":"A Kainz","year":"2000","unstructured":"Kainz, A., Harabacz, I., Cowlrick, I. S., Gadgil, S. D. & Hagiwara, D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 70, 1718\u20131721 (2000).","journal-title":"Transplantation"},{"key":"BFnrgastro2015172_CR79","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ajmg.a.35223","volume":"158A","author":"M Hoeltzenbein","year":"2012","unstructured":"Hoeltzenbein, M.  et al. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. Am. J. Med. Genet. A 158A, 588\u2013596 (2012).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrgastro2015172_CR80","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.bpobgyn.2014.09.001","volume":"28","author":"S Constantinescu","year":"2014","unstructured":"Constantinescu, S.  et al. Breast-feeding after transplantation. Best Pract. Res. Clin. Obstet. Gynaecol. 28, 1163\u20131173 (2014).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"BFnrgastro2015172_CR81","unstructured":"World Health Organization. Human Reproduction Programme. Medical eligibility criteria for contraceptive use. Fourth Edition \n                    [online]\n                    \n                  , (2015)."},{"key":"BFnrgastro2015172_CR82","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.contraception.2010.02.014","volume":"82","author":"KM Curtis","year":"2010","unstructured":"Curtis, K. M., Jamieson, D. J., Peterson, H. B. & Marchbanks, P. A. Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States. Contraception 82, 3\u20139 (2010).","journal-title":"Contraception"},{"key":"BFnrgastro2015172_CR83","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.contraception.2010.02.007","volume":"82","author":"ME Paulen","year":"2010","unstructured":"Paulen, M. E., Folger, S. G., Curtis, K. M. & Jamieson, D. J. Contraceptive use among solid organ transplant patients: a systematic review. Contraception 82, 102\u2013112 (2010).","journal-title":"Contraception"},{"key":"BFnrgastro2015172_CR84","unstructured":"U.S. Preventive Services Task Force. Strength of evidence grading system \n                    [online]\n                    \n                  , (2012)."}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.172","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:52:57Z","timestamp":1684468377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2015.172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,13]]},"references-count":84,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFnrgastro2015172"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2015.172","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,13]]},"assertion":[{"value":"13 October 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}